The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Ketoprofen: A Review of Its Pharmacologic and Clinical Properties
Abstract
Ketoprofen (Orudis), a highly potent and safe nonsteroidal antiinflammatory drug of the propionic acid derivative group, was synthesized in France by Rhône‐Poulenc chemists in 1967, 3 years after the prototype ibuprofen. Ketoprofen was introduced in 1973 in France and the United Kingdom for antiinflammatory use. Today the drug is available in about 80 countries and has recently been approved in the United States for treatment of rheumatoid arthritis and osteoarthritis. The therapeutic experience with ketoprofen is estimated to have exceeded 3 million patient‐years. Double‐blind trials have established its therapeutic equivalence with aspirin, indomethacin, and ibuprofen in rheumatoid arthritis and with aspirin in osteoarthritis. Ketoprofen has a short half‐life, a simple metabolism, and a broad therapeutic window, and does not accumulate with multiple doses. These features contribute to a rapid onset of action, flexible dosing, and a reliable tolerance profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advances in prostaglandin and thromboxane research
Cagen, L. M. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90223-7 · Cited by 657
Renal effects of drugs that inhibit prostaglandin synthesis
Dunn, M. J., & Zambraski, E. J. (1980) · Kidney International · doi:10.1038/ki.1980.179 · Cited by 269
The effect of organic acids on renal clearance of methotrexate in man
Liegler, D. G., Henderson, E. S., Hahn, M. A., & Oliverio, V. T. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1969106849 · Cited by 264
Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils.
Goetzl, E. J., & Sun, F. F. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.2.406 · Cited by 260
Thyss, A., Kubar, J., Milano, G., Namer, M., & Schneider, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90786-5 · Cited by 251
Higgs, G. A., Eakins, K. E., Mugridge, K. G., Moncada, S., & Vane, J. R. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90297-6 · Cited by 243
Acute Oliguric Renal Failure Induced by Indomethacin: Possible Mechanism
WALSHE, J. J., & VENUTO, R. C. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-1-47 · Cited by 207
PYRIDOXINE AND SERUM CONCENTRATION OF PHENYTOIN AND PHENOBARBITONE
Hansson, O., & Sillanpaa, M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91385-4 · Cited by 201
Pharmacokinetics of ketoprofen in the elderly.
Advenier, C., Roux, A., Gobert, C., Massias, P., Spreux‐Varoquaux, O., & Flouvat, B. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02145.x · Cited by 88
Effects of probenecid on ketoprofen kinetics
Upton, R. A., Williams, R. L., Buskin, J. N., et al. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.99 · Cited by 69
Cited by
Transdermal delivery of ketoprofen using microemulsions
Rhee, Y.-S., Choi, J.-G., Park, E.-S., & Chi, S.-C. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00827-4 · Cited by 321
Ferreira, L. M., Sari, M. H. M., Cervi, V. F., Gehrcke, M., Barbieri, A. V., Zborowski, V. A., Beck, R. C. R., Nogueira, C. W., & Cruz, L. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.008 · Cited by 54
Metadata
- Authors
- Kantor, T. G.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 1986-05-06
- Volume
- 6
- Issue
- 3
- Pages
- 93-102
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W1480805659
- Cited by
- 314
- References
- 16
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketoprofen: A Review of Its Pharmacologic and Clinical Properties. https://app.cochat.ai/papers/10.1002/j.1875-9114.1986.tb03459.x
- The paper
- Kantor, T. G. (1986). Ketoprofen: A Review of Its Pharmacologic and Clinical Properties. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/j.1875-9114.1986.tb03459.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.